In a Fierce Pharma Week panel, experts including Coalition for Healthcare Communication Director James Potter discussed why President Donald Trump’s threats to drug advertising may be more bark than bite. More: 'Keep doing what you're doing': Marketing policy experts unfazed
read moreAs Robert F. Kennedy Jr.’s revamped CDC vaccine advisory panel gears up to meet next week, U.S. health officials are reportedly planning to connect the deaths of 25 children to the use of COVID shots. More: Trump officials eye connection
read moreAmid the Trump administration’s call for a crackdown on direct-to-consumer pharmaceutical advertising, a new survey shows that many people with chronic conditions have been inspired by such ads to take some sort of action for their health. More: Chronic disease
read moreA federal judge granted Gilead summary judgment in a lawsuit that claimed the company used sham speaker events to induce doctors to write hepatitis C drug prescriptions. More: Gilead prevails in whistleblower lawsuit over alleged hepatitis C prescription kickbacks Source:
read moreA week after rejecting an appeal from BMS and J&J on the IRA price negotiation program, the same court has turned down a similar appeal from Novartis. More: Appeals court knocks back Novartis’ IRA challenge one week after rejecting bid
read more© 1994 - 2026 B.M. Pharmaceuticals